Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic age

Details Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic age Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic age

1994-01-27

1996-01-02

Gerstl, Robert

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

548132, C07D27107, A61K 3141

Patent

active

054808960

ABSTRACT:
This invention relates to novel compounds having antihyperglycemic properties of the formula: ##STR1## where A is ##STR2## wherein:

REFERENCES:
patent: 5002953 (1991-03-01), Hindley
patent: 5183825 (1993-02-01), Kees
Goldstein et al., J. Med. Chem. 36, 2238-2240 (1993).

Affiliated with

Also associated with

Rating

Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic age does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic age will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-235424